Back to top

World Hepatitis Summit 2024

The World Health Organization (WHO) will release its 2024 Global Hepatitis Report on the opening day of the World Hepatitis Summit (WHS) 2024, taking place in Lisbon, Portugal on 9 -11 April. It is the first consolidated report on viral hepatitis epidemiology, service coverage and product access, with improved data for action.

With information from 187 countries, the report outlines regional perspectives and actionable steps to scale up interventions, emphasizing the importance of leveraging lessons from the COVID-19 response. WHO will issue a press release on 9 April.

At the Summit, global experts and Ministry of Health programme managers will discuss the latest advances in hepatitis prevention, diagnosis and treatment, and share updates on innovative approaches to increase viral hepatitis services and address stigma and discrimination, with an aim for viral hepatitis elimination by 2030.

The World Hepatitis Alliance (WHA) and The European Centre for Disease Prevention and Control (ECDC) will present a first-of-its-kind report examining levels of stigma and discrimination surrounding people living with hepatitis in Europe.

Eliminating the stigma surrounding hepatitis through the introduction of policies and structural changes has been named a key factor in hepatitis elimination by WHO.

The World Hepatitis Summit

Is organized by the World Hepatitis Alliance, with the support of the Ministry of Health of Portugal and is co-sponsored by WHO. Its mission is to support countries in meeting the targets needed to eliminate viral hepatitis. It is being held in Lisbon and virtually.
More information here:

The Viral Hepatitis

Is inflammation of the liver caused by a virus, leading to a range of health problems, some of which are fatal. Hundreds of millions of people are living with viral hepatitis and over a million lose their lives every year because of conditions related to acute hepatitis and chronic infection that cause liver cancer and cirrhosis. Despite there being a vaccine and effective treatment for hepatitis B and a cure for hepatitis C – few countries in the world are on track to achieve the WHO target of eliminating viral hepatitis by 2030.

The World Hepatitis Alliance and European Centre for Disease Prevention and Control survey

The survey on stigma and discrimination related to hepatitis has been developed in partnership between the World Hepatitis Alliance and the European Centre for Disease Prevention and Control (ECDC) and with the input of European and global stakeholders and people with lived experience of hepatitis. This survey is the first survey of stigma and discrimination related to hepatitis to be conducted in the European region.